HonorStocks Biotech Gold Oil Mining China Asian MENU
Biotech Gold Oil Mining China Asian
Find Tomorrow's Winners Today

Stock technical analysis
Rating Flag Rating Flag Rating Flag Rating Flag Rating Flag
sell neutral buy
Achieve Life Sciences, Inc. (ACHV)
0.4372  0.034  (8.43%) 07-07 15:11
Open: 0.41 High: 0.45
Pre.close: 0.4032 Low: 0.405
Volume: 5,278,630 Ave vol: 1,105,156
52w High: 2.51 52w Low: 0.23
MA(50): 0.418 MA(200): 0.444
EPS: -0.966 P/E Ratio: 0
Company profile
Exchange: NASDAQ
Sector: Healthcare
Industry: Biotechnology
Website: http://www.achievelifesciences.com
Market Cap (M): 16
Shares Out (M): 38
Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and commercializes cytisinicline for smoking cessation and nicotine addiction in the United States and internationally. Its product candidate include cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain to help reduce the severity of nicotine withdrawal symptoms. The company has license agreements with Sopharma AD and University of Bristol; and a strategic collaboration with National Institutes of Health for the development of cytisinicline for smoking cessation. Achieve Life Sciences, Inc. was incorporated in 1991 and is based in Vancouver, Canada.
Technical analysis
Overall: Buy
MA: Bearish MACD: Bullish
KDJ: Bullish RSI: Bullish
Target 1: 0.58 Target 2: 0.68
Resist 1: 0.50 Resist 2: 0.58
Support 1: 0.37 Support 2: 0.31
Company key metrics
Revenue per Share: 0
Net Income per Share: -1.9881
Cash per Share: 0.002
Book Value per Share: 0.0022
Price to Sales: 0
Price to Book Value: 251.2753
Earnings Yield: -3.6148
Dividend Yield: 0
Debt to Equity: 0.1678
Debt to Assets: 0.1437
Financial analysis
Price to Book Value: Outperform
Return on Assets: Underperform
Return on Equity: Underperform
Discounted cash flow: Outperform
Price to Earnings: Underperform
Debt to Equity: Neutral
Stock Charts
Headline news
Tue, 07 Jul 2020
After A -23.91% Fall This Year Is Achieve Life Sciences, Inc. (NASDAQ:ACHV) A Better Buy Than Others? - Marketing Sentinel

Tue, 07 Jul 2020
Achieve Life Sciences, Inc. (ACHV) Sitting On The Launchpad, Waiting For The Long Term Buyers - Stocks Register

Mon, 29 Jun 2020
Achieve Life Sciences Announces Pricing of $6 Million Registered Direct Offering - Chinook Observer

Tue, 30 Jun 2020
Achieve Life Sciences, Inc. (ACHV): What is good about stock? - Marketing Sentinel

Thu, 18 Jun 2020
Think You Need A Good Stock? Look At This Achieve Life Sciences, Inc. (NASDAQ:ACHV) Analysis - Stocks Register

Mon, 29 Jun 2020
Achieve Life Sciences (ACHV) Successful Results from Investigator-Initiated RAUORA Head-to-Head Non-Inferiority Clinical Trial Comparing Cytisinicline and Chantix as Treatment to Quit Smoking - StreetInsider.com

HonorStocks, Find Tomorrow's Winners Today

©HonorStocks.com | U.S. stock markets, stock quotes and stock analysis. Data and information is provided for informational purposes only, is not intended for trading purposes and is not investment advice. Neither HonorStocks.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Market data provided by: IEX and Financial Modeling Prep

Privacy Policy: Third parties, including Google, may be placing and reading cookies on your browsers, or other methods to collect information as a result of ad serving on this website. Google's use of advertising cookies enables it and its partners to serve ads to you based on your visit to this site and/or other sites on the Internet. You may opt out of personalized advertising by visiting Ads Settings. If you choose to use this website, you agree to the collection and use of information in relation to this policy. The information collected is used for providing and improving the ads Service. We will not use or share information with anyone, and we do not store any data from users.